Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches – functional and prognastic information
- 1 February 2001
- journal article
- Published by Springer Nature in Leukemia
- Vol. 15 (2) , 275-277
- https://doi.org/10.1038/sj.leu.2402023
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemiaLeukemia, 1999
- Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNABritish Journal of Haematology, 1998
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphataseThe Journal of Pathology, 1998
- Detection of Neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT–PCR and anti-Ganglioside GD2 immunocytochemistryEuropean Journal Of Cancer, 1997
- Evaluation of Ki-67 Reactivity in Neuroblastoma Using Paraffin Embedded TissuePathology - Research and Practice, 1995
- Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patientsThe Lancet, 1993
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI Journal of the National Cancer Institute, 1993
- Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in NeuroblastomaNew England Journal of Medicine, 1991